• Kathy T Vo, Howard Horng, Kai Li, Raymond Y Ho, WuAlan H BAHBDepartment of Laboratory Medicine, University of California, San Francisco., Kara L Lynch, and Craig G Smollin.
• Department of Emergency Medicine, University of California, San Francisco; California Poison Control System, San Francisco Division. Electronic address: kathy.vo@ucsf.edu.
• Ann Emerg Med. 2018 Mar 1; 71 (3): 306-313.

Study ObjectiveCannabis and its principal active constituent, Δ9-tetrahydrocannabinol (THC), are increasingly available as edibles resembling commercially available food products. In this case series, we describe a population of predominantly pediatric patients who were inadvertently exposed to a THC-containing product in San Francisco.MethodsTwelve children and 9 adults were identified, with 16 patients having detectable serum THC and THC metabolites. All patients presented to hospitals with a variety of constitutional symptoms and all were discharged home within 12 hours.ResultsIn general, pediatric patients had more severe symptoms and longer hospital length of stay, and, uniquely, a majority presented with leukocytosis and elevated lactic acid levels.ConclusionWe recommend that efforts be made to increase general public awareness in regard to the potential hazards of THC-containing edibles resembling commercially available food products.Copyright © 2017 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

26 keywords...

hide…